These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1925 related articles for article (PubMed ID: 16686717)
1. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717 [TBL] [Abstract][Full Text] [Related]
2. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396 [TBL] [Abstract][Full Text] [Related]
3. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial. Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573 [TBL] [Abstract][Full Text] [Related]
4. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia. Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345 [TBL] [Abstract][Full Text] [Related]
5. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311 [TBL] [Abstract][Full Text] [Related]
6. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785 [TBL] [Abstract][Full Text] [Related]
7. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate. Matoka DJ; Averch TD Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529 [TBL] [Abstract][Full Text] [Related]
8. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565 [TBL] [Abstract][Full Text] [Related]
9. Holmium laser prostatic resection for patients presenting with acute urinary retention. Anderson CB; Helfand BT; McVary KT BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443 [TBL] [Abstract][Full Text] [Related]
11. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. Kumar SM J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231 [TBL] [Abstract][Full Text] [Related]
12. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. Pfitzenmaier J; Gilfrich C; Pritsch M; Herrmann D; Buse S; Haferkamp A; Djakovic N; Pahernik S; Hohenfellner M BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772 [TBL] [Abstract][Full Text] [Related]
13. Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate. Cho MC; Kim HS; Lee CJ; Ku JH; Kim SW; Paick JS Urology; 2010 Jun; 75(6):1460-6. PubMed ID: 19963247 [TBL] [Abstract][Full Text] [Related]
14. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. Elmansy HM; Elzayat E; Elhilali MM J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828 [TBL] [Abstract][Full Text] [Related]
15. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Sandhu JS; Ng C; Vanderbrink BA; Egan C; Kaplan SA; Te AE Urology; 2004 Dec; 64(6):1155-9. PubMed ID: 15596189 [TBL] [Abstract][Full Text] [Related]
16. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate. Paick JS; Um JM; Kwak C; Kim SW; Ku JH Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922 [TBL] [Abstract][Full Text] [Related]
17. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series. Helfand B; Mouli S; Dedhia R; McVary KT J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158 [TBL] [Abstract][Full Text] [Related]
18. [Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with oral anticoagulant therapy]. Hori Y; Kuromatsu I; Sugimura Y Hinyokika Kiyo; 2008 Oct; 54(10):651-6. PubMed ID: 19048929 [TBL] [Abstract][Full Text] [Related]
19. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441 [TBL] [Abstract][Full Text] [Related]
20. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Bachmann A; Ruszat R; Wyler S; Reich O; Seifert HH; Müller A; Sulser T Eur Urol; 2005 Jun; 47(6):798-804. PubMed ID: 15925076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]